Dr. Camras, inventor of most effective glaucoma drug, dies

Carl Camras, M.D., the University of Nebraska Medical Center physician whose research led to the discovery of the most effective drug for treating glaucoma, died Tuesday at his home in Omaha after a long battle with heart failure.

Dr. Camras, who was 55, served as chairman of the UNMC Department of Ophthalmology and Visual Sciences since 2000. He came to UNMC in 1991 as a tenured professor of ophthalmology.
 
A native of Chicago, Dr. Camras devoted more than 20 years of his career to looking for a better drug to treat glaucoma. His quest began as an undergraduate student at Yale University and continued in medical school at Columbia University College of Physicians and Surgery. At Columbia, he studied under Laszlo Bito, Ph.D., a legendary researcher-novelist from Hungary who worked at Columbia from 1966 to 1998.
 
As a biochemistry major at Yale, Dr. Camras first conceived the idea that prostaglandins, a type of hormone found in virtually all tissues and organs, could lower the increased intraocular pressure that occurs with glaucoma. In 1996, using prostaglandins, Drs. Bito and Camras were the lead investigators in developing a new drug – latanoprost – for treatment of glaucoma.
 
The drug, sold under the trade name of Xalatan, was first marketed by Pharmacia. In short order, it became the most effective drug for the treatment of glaucoma. Since Xalatan was created, two additional glaucoma drugs using prostaglandins – Travatan and Lumigan – have reached the market place. With annual sales exceeding $2 billion, the three glaucoma drugs are by far the most lucrative ophthalmic pharmaceutical products in history.
 
Glaucoma is a disease caused by increased intraocular pressure (IOP) resulting either from a malformation or malfunction of the eye’s drainage structures. Left untreated, an elevated IOP causes irreversible damage to the optic nerve and retinal fibers resulting in a progressive, permanent loss of vision. Early detection and treatment can slow or even halt progression of the disease. 
 
Glaucoma is a leading cause of blindness affecting more than 2 million people in the United States. It’s estimated that another million people have glaucoma but have not been diagnosed.
 
“Carl Camras was a genius and one of the leading glaucoma specialists in the world,” said Tom Hejkal, M.D., professor of ophthalmology at UNMC. “I would have said the leading glaucoma specialist in the world, but I know Carl’s modesty would have prompted him to refuse such high praise. 
 
“Not only did Carl know all of the scientific literature in his field, but he knew most of the authors personally, where they went to school, their hobbies and the names of their spouses and children. Carl was also one of the kindest and most generous men I have had the privilege to know.”
 
Dr. Camras’ incredible research portfolio includes more than 280 published articles in scientific journals. His impact on glaucoma patients could possibly continue even after his death, as he has a patent on a glaucoma shunt which could help patients in years to come. He has been an invited speaker at literally hundreds of national and international conferences.
 
“Carl was a great physician and leader,” said UNMC Chancellor Harold M. Maurer. “His research on glaucoma benefitted people around the globe. He had a ‘soft’ heart and was loved and respected by his patients and colleagues alike. We extend our deepest sympathy to his wife, Nancy, and to the entire family. His life was cut short, a loss to humanity.”
 
After completing medical school, Dr. Camras did his internship and residency training at the University of California at Los Angeles (UCLA) School of Medicine. He then completed a fellowship in glaucoma at Mount Sinai School of Medicine in New York City. He remained on the faculty at Mount Sinai from 1983 to 1991, when he accepted the position at UNMC.
 
Being an inventor came naturally to Dr. Camras. His late father, Marvin Camras, owned some 550 patents. An engineer in Chicago, Marvin’s research focused on preserving sound rather than sight. He invented magnetic recording, which was a forerunner to modern tape recording. The magnetic coatings he developed were used on VCR tapes and computer disks.
 
A recurring theme for all who knew Dr. Camras was the outstanding character of the man. “One of Carl’s greatest qualities was the way he treated all people with respect,” Dr. Hejkal said. “He treated even young students just starting out in his laboratory as colleagues and showed them as much consideration and respect as he showed the chairman of an ophthalmology department or the dean of a medical school.”
 
Survivors include: his mother, Isabelle Camras, Chicago; his brothers, Robert and Louis, both of Chicago, and Michael, San Francisco; a sister and brother-in-law, Ruth and Charlie Pikler, Chicago; his wife, Nancy; and two daughters, Lucinda and Melanie.
 
Continuing the family tradition of seeking new inventions, Lucinda, a graduate student in biomedical engineering at Duke University, has been working with her father on glaucoma drainage devices. Last May, father and daughter presented on the devices at a major glaucoma symposium hosted by UNMC.
 
The leading glaucoma experts in the world came to Omaha and made presentations at the symposium – most out of respect for Dr. Camras and his outstanding contributions to the field.  
 
UNMC is the only public health science center in the state. Its educational programs are responsible for training more health professionals practicing in Nebraska than any other institution. Through their commitment to education, research, patient care and outreach, UNMC and its hospital partner, The Nebraska Medical Center, have established themselves as one of the country’s leading centers in cancer, transplantation biology, bioterrorism preparedness, neurodegenerative diseases, cardiovascular diseases, genetics, biomedical technology and ophthalmology. UNMC’s research funding from external sources now exceeds $82 million annually and has resulted in the creation of more than 2,600 highly skilled jobs in the state. UNMC’s physician practice group, UNMC Physicians, includes 513 physicians in 50 specialties and subspecialties who practice primarily in The Nebraska Medical Center. For more information, go to UNMC’s Web site at www.unmc.edu.
 
 Memorial Service::
 
A memorial service for Dr. Camras will be held at 1 p.m., Sunday, at Heafey-Heafey-Hoffmann-Dworak-Cutler Funeral Chapel, 7805 W. Center Rd.
 
In addition, a second memorial service for the UNMC community will be held at 4 p.m., Friday, in the Mary Ann “Maisie” Paustian Amphitheater, Room 3001 of the Michael F. Sorrell Center for Health Science Education.
 
In lieu of flowers, the family requests that donations be made to the Camras Memorial Fund at the University of Nebraska Foundation. The Web site is being developed and gifts may be made online early next week at www.nufoundation.org.
   
What others are saying:
 
“Carl always looked at life as a challenge, a puzzle that needed to be answered, and in his optimism, we really shouldn’t be sad but celebrate that in our lifetime, we have been blessed with one very remarkable yet humble man who has touched millions of lives. We both agreed – one’s death should never be viewed as sad and solemn, but a time of celebration. Carl will be forever immortalized in the annals of ophthalmology, but more importantly, his passion and dedication will live on in the people he has touched. He would want us to continue his mission to build this clinic and research facility into one of the best. We owe it to him. But for now, like many others, I shall weep in silence.”
Donna Neely, clinic case manager, UNMC Physicians Eye Specialties

“Not a day goes by in clinic or in the OR that I don’t recall some pearl I learned from you….clinical pearls but also pearls in dealing with patients and colleagues in a compassionate and professional manner. I learned that the patients don’t exist for me but rather I exist as a physician for the patient’s benefit. I knew I was part of a good thing during residency but only now that I’m out in the ‘real world’ do I realize just how fortunate I was to learn from you. You can never know how much of an influence you have had on my life.”
Josh Zastrocky, M.D., who did his residency and glaucoma fellowship at UNMC and is now practicing in Durango, Colo.
 
“Carl had a deep appreciation of how basic research insights can eventually lead to medical cures. His leadership and support for basic research is evident in the doubling of ophthalmology faculty in basic research and construction of state-of-the-art research facilities in the Stanley Truhlsen Eye Research Laboratories. One of his dreams was to build a world-class Eye Institute at UNMC, and I believe we are finally close to making this dream come true. Carl worked harder than anyone in the department. I would see his office alight when arriving at 7 a.m., and he would still be there if I drove past the office at 8 p.m. Balancing his love for his job, Carl also loved to socialize, and he and his wife Nancy threw huge parties a number of times each year. 
 
“Carl’s memory of glaucoma-related publications seemed at least as comprehensive as and better catalogued than PubMed. He could recall the authors, study, and specific findings of impressive numbers of publications conducted over decades. Right up to the end, he was much more concerned about how others were doing than he was about himself and his own health.”
Wallace Thoreson, Ph.D., professor and vice chairman for research, ophthalmology and visual sciences
 
“Dr. Camras is the greatest human being that I have ever known. He is the most ethical person with the highest values, incredibly brilliant, a wonderful physician and researcher, yet very humble, compassionate, caring and always thinking of others. He remembered birthdays and special events of all those around him. He knew our families, our life’s stories, joys and sorrows and remembered them. He never failed to say thank you and express his appreciation for anything that was done for him. 
 
“Dr. Camras was loved by his patients, despite some of them having long waits to see him. They brought food, handmade afghans, letters and other gifts. He was legendary at ophthalmology meetings for always being on the run. He would be in a suit with his tennis shoes. He had a prolific agenda for every meeting that he carefully planned out in advance.”
Kathy Austin, administrative director, department of ophthalmology and visual sciences
 
“He was one of the chairmen I hired when I was dean of the College of Medicine, and I will always be proud of that. Carl was a wonderful person, an internationally famous ophthalmologist and a great leader. I value his friendship. He was as kind and generous a person as you will ever meet. He lived life to the fullest having conquered a potentially fatal disease (Hodgkin’s disease) as a young man. He never allowed illness or not feeling the best to be a reason for not excelling.”
James Armitage, M.D., professor, internal medicine, section of oncology-hematology
 
“Your body looks a little beat up but you are still Carl on the inside. There you were, praising and thanking me for my small gestures and contributions to the department yet you won’t listen to any praise or thanks yourself. Typical, humble Carl. You have mentored me for a good 15 years now. I will do my best to live up to your expectations and standards. Thank you for leading and growing the department over the past nine years. We look forward to seeing that Eye Institute built and the department grow even more. Thank you for your many small gestures such as the parties that united the department and the lunches to celebrate birthdays….and thanks for being my chairman, mentor, colleague and friend.You are irreplaceable.
Carol Toris, Ph.D., professor of ophthalmology (in a letter she wrote to Dr. Camras after visiting him)
 
“Tears are flowing down my cheeks, as I attempt to express my profound admiration and affection for you. I remember a time at an academy meeting – I think it was in New Orleans – when I had just arrived and was walking from a meeting to my hotel, and you not only walked the entire way with me – it was quite a few blocks – but insisted on carrying my bag. That moment has always stuck in my mind as an example of what a wonderful and considerate friend you have always been to so many people. Old friend, I honestly believe that we will all be together again one day. And until that day, I will never hesitate to tell whoever I meet about one of the finest men I ever knew.”
Bruce Shields, M.D., professor and chairman emeritus of ophthalmology & visual science department, Yale University
 
“Dr. Camras endured a long battle with heart failure from restrictive pericarditis, which was a complication of the radiation therapy he received for treatment of Hodgkin’s disease more than 25 years ago. Through his extensive review of the literature on this subject over the last two years, I believe he knew more about this condition than most of the experts in the field. I am confident that, given a little more time in good health, he would have discovered a cure.”
Tom Hejkal, M.D., professor and vice chairman of clinical care, ophthalmology and visual sciences
 
“I’ve never seen a person who can get so much done in such as short time as Carl. What an incredible guy he is…amazing and inspirational to so many people…and the true definition of a genius, but one of the nicest, most humble souls to inhabit the planet.
I can remember standing in the Eye Clinic hallways doing time studies on how long it took us to move patients in and out of exam rooms. Whenever a patient was waiting for Carl, I always knew where to look for him – in his office cranking out as much as he could on a research paper in the span of 2-5 minutes between patients. He just could not waste one moment of any day. Carl loved his family, his work and his colleagues. He is truly beloved and an icon.” 
Lisa Runco, administrator, department of internal medicine
 
“Carl was an internationally recognized and respected glaucoma specialist. He elevated the UNMC Department of Ophthalmology to national prominence both clinically and through research. It was my good fortune to be associated with Carl throughout his UNMC career. He was a friend. His legacy of well trained ophthalmologists, his
participation in the development of latanoprost (Xalatan) a treatment for glaucoma used worldwide as an initial treatment of choice, and his research contributions all added to the growing reputation of UNMC. Carl was a physician who cared deeply about his patients.”
Stanley M. Truhlsen, M.D., emeritus professor and chairman,
ophthalmology and visual sciences, and longtime donor to UNMC who created the Truhlsen Eye Research Laboratories in the Durham Research Center

“Carl Camras is undoubtedly one of the most extraordinary individuals I have known. Despite his lingering illness he continued to perform his leadership responsibilities, to care for his numerous patients and to place his needs behind those of others. Amongst an array of talents, Carl had a photographic memory, and he was always the first to ask after your family or to remember an alumnus or colleague. Carl lived life to the fullest. I will truly miss him and his friendship.”
John Gollan, M.D., Ph.D., dean, UNMC College of Medicine